Published in Vaccine Weekly, October 31st, 2007
BiovaxID has been in human clinical studies since 1993. Non-Hodgkins Lymphoma is an indolent but typically fatal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.